| 1 | ASCO | 2.47% | |
| 2 | Patients | 1.54% | |
| 3 | Risk | 1.23% | |
| 4 | May | 1.23% | |
| 5 | Cancer | 0.93% | |
| 6 | Status | 0.93% | |
| 7 | Study | 0.93% | |
| 8 | Treatment | 0.93% | |
| 9 | Use | 0.93% | |
| 10 | Disease | 0.93% | |
| 11 | CDC | 0.62% | |
| 12 | Outcomes | 0.62% | |
| 13 | New | 0.62% | |
| 14 | Salmonella | 0.62% | |
| 15 | Number | 0.62% | |
| 16 | mCRPC | 0.62% | |
| 17 | Report | 0.62% | |
| 18 | Efficacy | 0.62% | |
| 19 | Case | 0.62% | |
| 20 | Gene | 0.62% | |
| 21 | Data | 0.62% | |
| 22 | MIBC | 0.62% | |
| 23 | According | 0.62% | |
| 24 | HIV | 0.62% | |
| 25 | Response | 0.62% | |
| 26 | Checkpoint | 0.62% | |
| 27 | Cardiovascular | 0.62% | |
| 28 | Versus | 0.62% | |
| 29 | Tumor | 0.62% | |
| 30 | Immune | 0.62% | |
| 31 | Protein | 0.62% | |
| 32 | Phase | 0.62% | |
| 33 | Stroke | 0.62% | |
| 34 | Clear | 0.31% | |
| 35 | Caused | 0.31% | |
| 36 | Dog | 0.31% | |
| 37 | Strategies | 0.31% | |
| 38 | Signs | 0.31% | |
| 39 | Tied | 0.31% | |
| 40 | Deaths | 0.31% | |
| 41 | Effectiveness | 0.31% | |
| 42 | Resistance | 0.31% | |
| 43 | Burden | 0.31% | |
| 44 | Low- | 0.31% | |
| 45 | Supernumerary | 0.31% | |
| 46 | Biomarkers | 0.31% | |
| 47 | Durvalumab | 0.31% | |
| 48 | Spacer | 0.31% | |
| 49 | Value | 0.31% | |
| 50 | Inhibitor | 0.31% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||